DrugPatentWatch Database Preview
Email this page to a colleague» See Plans and Pricing
« Back to Dashboard
Motrin Ib is a drug marketed by J And J Consumer Inc and is included in one NDA.
The generic ingredient in MOTRIN IB is ibuprofen. There are sixty-four drug master file entries for this compound. Two hundred and twenty-two suppliers are listed for this compound. Additional details are available on the ibuprofen profile page.
A generic version of MOTRIN IB was approved as ibuprofen by OHM on July 15th, 1986.
Recent Clinical Trials for MOTRIN IB
Identify potential brand extensions & 505(b)(2) entrants
|Boston University||Phase 4|
|University of Colorado, Denver||Early Phase 1|
|University of Utah||Early Phase 1|
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|J And J Consumer Inc||MOTRIN IB||ibuprofen||TABLET;ORAL||019012-003||Dec 17, 1990||OTC||Yes||No||Start Trial||Start Trial||Start Trial|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|